 SOUTH SAN FRANCISCO, Calif., Nov. 22, 2022 GLOBE NEWSWIRE -- Tempest Therapeutics, Inc. Nasdaq: TPST, a clinical-stage oncology company focused on developing first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, today announced that management will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference on Tuesday, November 29, 2022 at 11:30 am ET. 